Neuroone Medical Technologies Stock Price Prediction
| NMTC Stock | USD 0.68 0.02 2.86% |
Oversold Vs Overbought
46
Oversold | Overbought |
Wall Street Target Price 3.15 | Quarterly Revenue Growth 0.311 |
Using Neuroone Medical hype-based prediction, you can estimate the value of Neuroone Medical Technologies from the perspective of Neuroone Medical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Neuroone Medical to buy its stock at a price that has no basis in reality. In that case, they are not buying Neuroone because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Neuroone Medical after-hype prediction price | USD 0.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Neuroone |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuroone Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neuroone Medical After-Hype Price Prediction Density Analysis
As far as predicting the price of Neuroone Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Neuroone Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Neuroone Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Neuroone Medical Estimiated After-Hype Price Volatility
In the context of predicting Neuroone Medical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Neuroone Medical's historical news coverage. Neuroone Medical's after-hype downside and upside margins for the prediction period are 0.03 and 5.40, respectively. We have considered Neuroone Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Neuroone Medical is extremely dangerous at this time. Analysis and calculation of next after-hype price of Neuroone Medical Tec is based on 3 months time horizon.
Neuroone Medical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Neuroone Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neuroone Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Neuroone Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 4.70 | 0.00 | 0.02 | 8 Events / Month | 5 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.68 | 0.70 | 0.00 |
|
Neuroone Medical Hype Timeline
Neuroone Medical Tec is now traded for 0.68. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. Neuroone is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at -0.14%. %. The volatility of related hype on Neuroone Medical is about 4061.73%, with the expected price after the next announcement by competition of 0.66. About 19.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.48. Neuroone Medical Tec had not issued any dividends in recent years. The entity had 1:3 split on the 1st of April 2021. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out Neuroone Medical Basic Forecasting Models to cross-verify your projections.Neuroone Medical Related Hype Analysis
Having access to credible news sources related to Neuroone Medical's direct competition is more important than ever and may enhance your ability to predict Neuroone Medical's future price movements. Getting to know how Neuroone Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Neuroone Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NPCE | Neuropace | (0.25) | 10 per month | 3.21 | 0.06 | 9.73 | (6.19) | 35.38 | |
| INGN | Inogen Inc | (0.43) | 6 per month | 0.00 | (0.17) | 2.66 | (4.81) | 22.50 | |
| SRDX | SurModics | (0.07) | 9 per month | 0.00 | (0.21) | 1.26 | (1.01) | 3.22 | |
| LUNG | Pulmonx Corp | (0.50) | 8 per month | 0.00 | (0.04) | 9.00 | (6.89) | 20.52 | |
| BMRA | Biomerica | 0.03 | 4 per month | 0.00 | (0.08) | 9.38 | (10.26) | 25.24 | |
| XAIR | Beyond Air | (0.04) | 5 per month | 6.37 | 0.05 | 10.42 | (8.70) | 32.60 | |
| BJDX | Bluejay Diagnostics | 0.45 | 3 per month | 0.00 | (0.1) | 13.03 | (13.14) | 120.52 |
Neuroone Medical Additional Predictive Modules
Most predictive techniques to examine Neuroone price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neuroone using various technical indicators. When you analyze Neuroone charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Neuroone Medical Predictive Indicators
The successful prediction of Neuroone Medical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Neuroone Medical Technologies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Neuroone Medical based on analysis of Neuroone Medical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Neuroone Medical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Neuroone Medical's related companies. | 2021 | 2022 | 2024 (projected) | Payables Turnover | 0.26 | 2.18 | 0.67 | Days Of Inventory On Hand | 1.1K | 421.31 | 430.43 |
Story Coverage note for Neuroone Medical
The number of cover stories for Neuroone Medical depends on current market conditions and Neuroone Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neuroone Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neuroone Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Neuroone Medical Short Properties
Neuroone Medical's future price predictability will typically decrease when Neuroone Medical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Neuroone Medical Technologies often depends not only on the future outlook of the potential Neuroone Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neuroone Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.1 M | |
| Cash And Short Term Investments | 5.3 M |
Complementary Tools for Neuroone Stock analysis
When running Neuroone Medical's price analysis, check to measure Neuroone Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuroone Medical is operating at the current time. Most of Neuroone Medical's value examination focuses on studying past and present price action to predict the probability of Neuroone Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuroone Medical's price. Additionally, you may evaluate how the addition of Neuroone Medical to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |